Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


A Neurology Clerkship Curriculum Using Video-Based Lectures and Just-in-Time Teaching (JiTT).

Dominguez M, DiCapua D, Leydon G, Loomis C, Longbrake EE, Schaefer SM, Becker KP, Detyniecki K, Gottschalk C, Salardini A, Encandela JA, Moeller JJ.

MedEdPORTAL. 2018 Mar 16;14:10691. doi: 10.15766/mep_2374-8265.10691.


Effectiveness of alternative dose fingolimod for multiple sclerosis.

Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I.

Neurol Clin Pract. 2018 Apr;8(2):102-107. doi: 10.1212/CPJ.0000000000000434.


Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS.

Baldassari LE, Salter AR, Longbrake EE, Cross AH, Naismith RT.

Mult Scler. 2018 Sep;24(10):1347-1355. doi: 10.1177/1352458517721357. Epub 2017 Aug 2.


Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.

Longbrake EE, Cantoni C, Chahin S, Cignarella F, Cross AH, Piccio L.

Mult Scler. 2018 May;24(6):728-738. doi: 10.1177/1352458517707069. Epub 2017 May 8.


Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.

Longbrake EE, Lancia S, Tutlam N, Trinkaus K, Naismith RT.

Mult Scler Relat Disord. 2016 Nov;10:198-203. doi: 10.1016/j.msard.2016.10.009. Epub 2016 Nov 4.


The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.


Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail.

Longbrake EE, Hafler DA.

JAMA Neurol. 2016 Jul 1;73(7):777-8. doi: 10.1001/jamaneurol.2016.1227. No abstract available.


An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.

Wu GF, Longbrake EE.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 7;3(2):e218. doi: 10.1212/NXI.0000000000000218. eCollection 2016 Apr. No abstract available.


Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.

Longbrake EE, Cross AH.

JAMA Neurol. 2016 Feb;73(2):219-25. doi: 10.1001/jamaneurol.2015.3977. Review.


Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice.

Longbrake EE, Cross AH, Salter A.

Mult Scler J Exp Transl Clin. 2016 Jan-Dec;2. doi: 10.1177/2055217316677868. Epub 2016 Nov 1.


Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.

Longbrake EE, Naismith RT, Parks BJ, Wu GF, Cross AH.

Mult Scler J Exp Transl Clin. 2015 Jan-Dec;1. pii: 2055217315596994. Epub 2015 Jul 31.


Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.

Longbrake EE, Ramsbottom MJ, Cantoni C, Ghezzi L, Cross AH, Piccio L.

Mult Scler. 2016 Jul;22(8):1061-1070. doi: 10.1177/1352458515608961. Epub 2015 Oct 12.


Dimethyl fumarate associated lymphopenia in clinical practice.

Longbrake EE, Cross AH.

Mult Scler. 2015 May;21(6):796-7. doi: 10.1177/1352458514559299. Epub 2014 Nov 28. No abstract available.


Monoclonal antibodies as disease modifying therapy in multiple sclerosis.

Longbrake EE, Parks BJ, Cross AH.

Curr Neurol Neurosci Rep. 2013 Nov;13(11):390. doi: 10.1007/s11910-013-0390-z. Review.


Susac syndrome in a patient with human immunodeficiency virus infection.

Longbrake EE, Ances BM, Viets RB, Clifford DB.

J Neurovirol. 2013 Jun;19(3):270-3. doi: 10.1007/s13365-013-0164-z. Epub 2013 May 21. No abstract available.


Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages.

Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, Ransohoff RM, Popovich PG.

J Neurosci. 2011 Jul 6;31(27):9910-22. doi: 10.1523/JNEUROSCI.2114-11.2011.


Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?

Longbrake EE, Racke MK.

Expert Rev Neurother. 2009 Mar;9(3):319-21. doi: 10.1586/14737175.9.3.319. Review.


Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats.

Detloff MR, Fisher LC, McGaughy V, Longbrake EE, Popovich PG, Basso DM.

Exp Neurol. 2008 Aug;212(2):337-47. doi: 10.1016/j.expneurol.2008.04.009. Epub 2008 Apr 20.


Can the immune system be harnessed to repair the CNS?

Popovich PG, Longbrake EE.

Nat Rev Neurosci. 2008 Jun;9(6):481-93. doi: 10.1038/nrn2398. Review.


Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour.

Holmes FE, Arnott N, Vanderplank P, Kerr NC, Longbrake EE, Popovich PG, Imai T, Combadière C, Murphy PM, Wynick D.

J Neurochem. 2008 Jul;106(2):640-9. doi: 10.1111/j.1471-4159.2008.05419.x. Epub 2008 Apr 12.


Characterization and modeling of monocyte-derived macrophages after spinal cord injury.

Longbrake EE, Lai W, Ankeny DP, Popovich PG.

J Neurochem. 2007 Aug;102(4):1083-94.

Supplemental Content

Loading ...
Support Center